A brief introduction of Bentham Science Brand Ambassador:
Bentham Science Ambassador Program, a project of Bentham Science, is an effort to liaison between the researcher and the publisher. This program will act as a tool to spread information and knowledge about Bentham content and initiatives among the research community. Through promoting Bentham Science content, the Bentham Science Ambassador encourages researchers to contribute to Bentham Science publications, and will in return be rewarded points for the tasks performed by them, which they could redeem through various offers & incentives by Bentham Science such as, Bentham Science eBooks, Open Access Journal, etc. This online portal will facilitate the ambassadors in performing their tasks.
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.